🔗 Permalink

Inventor profile of:

Massimo Iacobelli

City:

Milano

Country:

Italy

Published Applications:

Last publication date:

2023-03-16

Top Assignees for applications by Massimo Iacobelli

The entities that hold a legal rights for patent applications filed by inventor Iacobelli Massimo:

GENTIUM SPA 3 Villa Guardia (CO), Italy
GENTIUM S.P.A. 3 Villa Guardia, Italy
GENTIUM S.R.L. 2 Villa Guardia (CO), Italy
GENTIUM S.P.A. 1 Villa Guardia (Como), Italy
TIUM SPA 1 Milano, Italy
GENTIUM S.R.L. 1 Villa Guardia, Italy

Recent patent applications by Iacobelli Massimo

Massimo Iacobelli from Milano, IT has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2023-03-16

US20230084937A1

Human necessities

METHODS FOR TREATING PATIENTS HAVING SINUSOIDAL OBSTRUCTION SYNDROME

#2 | 2021-02-25

US20210052622A1

Human necessities

DEFIBROTIDE FOR USE IN PROPHYLAXIS AND/OR TREATMENT OF GRAFT VERSUS HOST DISEASE (GVHD)

#3 | 2019-10-31

US20190328765A1

Human necessities

METHODS FOR TREATING PATIENTS HAVING SINUSOIDAL OBSTRUCTION SYNDROME

#4 | 2017-10-26

US20170304349A1

Human necessities

DEFIBROTIDE FOR USE IN PROPHYLAXIS AND/OR TREATMENT OF GRAFT VERSUS HOST DISEASE (GVHD)

#5 | 2017-03-23

US20170080012A1

Human necessities

Defibrotide for use in prophylaxis and/or treatment of graft versus host disease (GVHD)

#6 | 2015-10-22

US20150297624A1

Human necessities

Defibrotide for use in prophylaxis and/or treatment of graft versus host disease (GVHD)

#7 | 2015-07-16

US20150196580A1

Human necessities

USE OF DEFIBROTIDE FOR THE INHIBITION OF HEPARANASE

#8 | 2014-12-11

US20140363394A1

Human necessities

Formulation having mobilizing activity

#9 | 2014-01-02

US20140005256A1

Human necessities

FORMULATIONS WITH ANTI-TUMOUR ACTION

#10 | 2013-09-05

US20130231470A1

Human necessities

Defibrotide for use in prophylaxis and/or treatment of Graft versus Host Disease (GVHD)

#11 | 2011-04-21

US20110092576A1

Chemistry; metallurgy

SYNTHETIC PHOSPHODIESTER OLIGONUCLEOTIDES AND THERAPEUTICAL USES THEREOF

#12 | 2010-11-25

US20100298413A1

Human necessities

USE OF OLIGOTIDE FOR THE TREATMENT OF RENAL DISEASES

#13 | 2010-10-07

US20100254938A1

Human necessities

Formulation having mobilising activity

#14 | 2009-05-21

US20090131362A1

Human necessities

USE OF DEFIBROTIDE FOR THE INHIBITION OF HEPARANASE

#15 | 2008-09-25

US20080234180A1

Human necessities

Use of sulglicotide for the treatment of mucositis

#16 | 2008-08-14

US20080194507A1

Human necessities

Defibrotide An/Or Oligodeoxyribonucleotides For Treating Angiogenesis-Dependent Tumors

#17 | 2008-08-14

US20080194506A1

Human necessities

Oligodeoxyribonuleotides of 4000-10000 Dalton for Treating

InventorID:

425822 ⎘